SCHEMBL4972006

SCHEMBL4972006

Cc1cccc([C@H](OCCN)[C@@H]2CCCN(C(C)(C)C)C2)c1

nearest known ligand 0.41

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
REN P00797 14/20 0.41
CYP3A4 P08684 2/20 0.33
HRH3 Q9Y5N1 2/20 0.33
SLC6A9 P48067 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3968254 0.88 REN (0.47) RENCYP3A4
SCHEMBL4973673 0.88 REN (0.47) RENCYP3A4
SCHEMBL4972485 0.83 REN (0.61) RENCYP3A4
SCHEMBL3881752 0.82 REN (0.52) RENHRH3
SCHEMBL2332375 0.81 REN (0.50) RENCYP3A4
SCHEMBL2332382 0.81 REN (0.50) RENCYP3A4
SCHEMBL2332378 0.81 REN (0.50) RENCYP3A4
SCHEMBL4974117 0.81 SLC6A2 (0.40) RENCYP3A4
SCHEMBL4971315 0.79 REN (0.49) RENCYP3A4
SCHEMBL4973471 0.79 REN (0.43) REN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1966139-A1 ASPARTIC PROTEASE INHIBITORS Vitae Pharmaceuticals, Inc. (US) 2008-09-10 EP disclosed
WO-2007070201-A1 ASPARTIC PROTEASE INHIBITORS VITAE PHARMACEUTICALS, INC. (US) 2007-06-21 WO disclosed